Therabest is a biopharmaceutical company that develops iPSC-derived immune cells. Our mission is to provide the benefits of cell therapy to many patients. We established a robust process that manufacture Armored iPSC CAR-NK, off-the-shelf cell products using our exclusive technology. Currently, our main pipeline is CD19 (Lymphoid tumor) and Muc1c (Solid tumor). We plan to expand our pipeline through collaboration with companies that own tumor target scFv.
Company Details
- Employees
- 14
- Founded
- -
- Address
- 41, Seocho-Daero 40-Gil, Seocho-Gu, 7f,daeho Ir Tower,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://therabest.co.kr/kr/
- Keywords
- aceRNA Technologies.
- HQ
- Seoul
Therabest Questions
Therabest's website is http://therabest.co.kr/kr/
Therabest's LinkedIn profile is https://kr.linkedin.com/company/therabest
Therabest has
14 employees.
View email and phone details for 14
employees at Therabest.
Therabest's industry is
Biotechnology Research
Therabest's top competitors are
Therabest,
Acerna Technologies,
Therabest Usa,
Quality Control Manufacturing,
Therabest,
Vigencell(바이젠셀),
Pulsebio Consulting,
Arbormed,
Beta Medical S.r.l.,
Physiosteps.
Therabest's categories are Biotechnology Research
Therabest's founding year is 2012
